Northside Hospital, Inc. - GCS/Northside — Atlanta, Georgia

Northside Hospital, Inc. - GCS/Northside is a clinical research site located in Atlanta, Georgia, United States 30342.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Northside Hospital, Inc. - GCS/Northside has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Breast Neoplasms, Locally Advanced or Metastatic Solid Tumors.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Atlanta

Browse all research sites in Georgia · View every site in Atlanta

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northside Hospital, Inc. - GCS/Northside?

Northside Hospital, Inc. - GCS/Northside has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northside Hospital, Inc. - GCS/Northside conducted?

Northside Hospital, Inc. - GCS/Northside has 4 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, Breast Neoplasms, Locally Advanced or Metastatic Solid Tumors.

Is Northside Hospital, Inc. - GCS/Northside accredited by Crixeo Clinical Trials?

Northside Hospital, Inc. - GCS/Northside has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northside Hospital, Inc. - GCS/Northside?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.